Search clinical trials for: Bevacizumab and eribulin

Total 271695 results

University Medical Center Groningen
Novartis

Completed

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage)

Metastatic Renal Cell Carcinoma

Netherlands
University Medical Center Groningen
VHL Alliance

Completed

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease (VHLimage)

Renal Cell Carcinoma | Von Hippel-Lindau Disease | Pheochromocytoma | Pancreatic Neuroendocrine Tumor | Hemangioblastoma

Netherlands
Pfizer

Completed

A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)

Healthy

United States
Asociación para Evitar la Ceguera en México

Terminated

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Macular Edema

Mexico
Shahid Beheshti University of Medical Sciences

Unknown

Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

Diabetic Retinopathy

Iran, Islamic Republic of
Yonsei University

Completed

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

Diabetic Retinopathy

Korea, Republic of
Fudan University

Not yet recruiting

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Metastatic Liver Cancer

China
University Medical Center Groningen

Completed

VEGF Imaging in Renal Cell Carcinoma (Renimage)

Renal Cell Carcinoma

Netherlands
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

Choroidal Neovascularization

Brazil
Fudan University

Recruiting

LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer

TNBC - Triple-Negative Breast Cancer

China
M.D. Anderson Cancer Center

Recruiting

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Refractory Solid Tumors

United States
The University of Texas Health Science Center at...

Withdrawn

Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients

Ovarian Cancer | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation
Memorial Sloan Kettering Cancer Center
Genentech, Inc.; Weill Medical College of Cornell University

Completed

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

Brain Cancer | Primary Brain Tumor | Recurrent Malignant Gliomas

United States
Genentech, Inc.

Completed

A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and Metastatic Colorectal Cancer (APM4566g)

Metastatic Colorectal Cancer
Hospices Civils de Lyon

Completed

Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH (BEST)

HHT | Hemorrhagic Hereditary Telangiectasia

France
Medical University of Lublin

Completed

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Exudative Age-related Macular Degeneration
Beth Israel Deaconess Medical Center
Massachusetts General Hospital; Dana-Farber Cancer Institute; Genentech, Inc.

Terminated

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Serous Cancer

United States
Eastern Regional Medical Center

Terminated

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

Malignant Ascites

United States
Genentech, Inc.

Completed

A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

Solid Cancers

United States
Yonsei University

Withdrawn

Corneal Thinning During Topical Bevacizumab Therapy

Corneal Neovascularization

Korea, Republic of
Sun Yat-sen University
Proswell Medical Corporation

Unknown

Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Seoul St. Mary's Hospital

Unknown

Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy

Diabetes Complications

Korea, Republic of
Amsterdam UMC, location VUmc

Terminated

Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer

Toxicity

Netherlands
Federal University of São Paulo

Unknown

Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

Macular Degeneration

Brazil
National Taiwan University Hospital

Unknown

Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation

Diabetic Retinopathy With Premacular Hemorrhage

Taiwan
Associacio catalana per a la recerca oncologica...
Hoffmann-La Roche

Unknown

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Rectal Neoplasms | Locally Advanced Rectal Adenocarcinoma

Spain
University Medical Center Groningen

Not yet recruiting

Safety and Feasibility of Immuno-OCT (DETOUR)

Barrett Esophagus | Colon Carcinoma | Gastrointestinal Dysplasia
Fudan University

Recruiting

The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Fudan University

Recruiting

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Colorectal Cancer

China
Massachusetts Eye and Ear Infirmary

Completed

Topical Avastin for Treatment of Corneal Neovascularization

Corneal Neovascularization

United States
Qilu Hospital of Shandong University
Renmin Hospital of Wuhan University; Moriggia-Pelascini Gravedona Hospital

Completed

Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP)

Coronavirus Infections

China, Italy
University Hospital, Limoges

Completed

Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea (BECONNEC)

Corneal Newvessels

France
Biocad

Withdrawn

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Neovascular Age-related Macular Degeneration
University of Campania "Luigi Vanvitelli"

Completed

Intravitreal Bevacizumab in Agioid Streaks

Choroidal Neovascularization | Angioid Streaks

Italy
University of Alabama at Birmingham

Completed

The Effect of Bevacizumab (Avastin) on Pterygium

Pterygium

United States
Emory University
Genentech, Inc.

Withdrawn

Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

Esophageal Carcinoma
Swiss Group for Clinical Cancer Research

Completed

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

Switzerland
Asociación para Evitar la Ceguera en México

Unknown

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular Degeneration | Choroidal Neovascularization

Mexico
National Taiwan University Hospital

Completed

Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy (VL)

Proliferative Diabetic Retinopathy

Taiwan
Northwestern University
Eisai Inc.

Unknown

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...

United States
National Cancer Institute (NCI)

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Sporadic Papillary Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Oropharyngeal Squamous... and other conditions

United States, Puerto Rico, South Africa
National Cancer Institute (NCI)
NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaborators

Active, not recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7

United States, Canada, Ireland, Peru, South Africa
National Cancer Institute (NCI)

Active, not recruiting

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Combined Hepatocellular Carcinoma and Cholangiocarcinoma | Stage III Liver Cancer | Stage IV Liver Cancer

United States
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Diabetic Retinopathy

Proliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic Retinopathy

Mexico
West Penn Allegheny Health System

Withdrawn

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Glioblastoma | Optic Neuropathy
University Medical Center Groningen

Completed

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW (FLASH)

Soft Tissue Sarcoma

Netherlands
Sun Yat-sen University

Unknown

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Bevacizumab | Brain Metastases | Sintilimab

China
Changhua Christian Hospital

Completed

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Choroidal Neovascularization | Punctate Inner Choroidopathy

Taiwan

Search clinical trials for: Bevacizumab and eribulin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations